Meldungen zum Thema Medizin, Gesundheit

iuvando Health GmbH

iuvando Health and Immatics collaborate to improve access to clinical trials for patients with metastatic melanoma

Mannheim (ots) - iuvando Health, a leading health tech company specializing in clinical trials matching and physician-led patient navigation support, today announced its collaboration with Immatics, the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and ...

STADA Arzneimittel AG

Press Release: STADA appoints Diana Wiedmann as Chief People Officer

D4L data4life gGmbH

Data4Life and Monash Health Announce Strategic Collaboration to Advance Clinical Research

Sysmex Europe SE

5

Sysmex launches fully automated HISCL HIT IgG Assay Kit to enhance heparin-induced thrombocytopenia (HIT) diagnosis accuracy and speed across EMEA

Polpharma Group

2

Polpharma Strengthens Its Position in Central and Eastern Europe – Biofarm, the Leader of the Romanian Market, Joins the Group

Grünenthal Group

Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich

Aachen, Germany (ots) - Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic ...

Ottobock SE & Co. KGaA

3

dynion explore: new prosthetic knee joint for adolescents

Acousia Therapeutics GmbH

Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity

Tübingen (ots) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its completed Phase 2a PROHEAR Study. ACOU085 is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across ...

Virchow Foundation

The Virchow Prize 2026 Awarded for Pioneering Work on Ebola, Advancing Global Epidemic Preparedness and Fostering Global Solidarity

PNO Innovation GmbH

Press invitation: 1st System Field Test | Botkyrka, Sweden on 16.06.2026

Ottobock SE & Co. KGaA

2

iconiq: Individualized liner from a 3D printer

Ottobock SE & Co. KGaA

5

Back in motion: Peggy’s rehabilitation success after a serious motocross accident

Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA categorically rejects misleading allegations in short-seller report

Ottobock SE & Co. KGaA

Annual General Meeting approves dividend of EUR 0.97 per share

Ottobock SE & Co. KGaA

Ottobock continues strategic expansion of its Patient Care network with acquisition

Ottobock SE & Co. KGaA

6

Ottobock will be presenting innovative prosthetics and orthotics solutions at OTWorld 2026.

Europäischer Rechnungshof - European Court of Auditors

Koronakriisin jälkeinen miljardien eurojen arvoinen EU:n elpymisrahasto ei ole riittävän avoin

GEA Group Aktiengesellschaft

Interview with Intellicant-Experte Fabien Patrick

GEA Group Aktiengesellschaft

4

GEA presents a smart decanter at IFAT 2026

Technische Universität München

Stem Cell Research: Reading Genetic Activity from Living Cells without Destroying Them

TECHNICAL UNIVERSITY OF MUNICH PRESS RELEASE Tool for Better Control of Stem Cell Development Reading Genetic Activity from Living Cells without Destroying Them - Multi-day gene activity profiles from the same cells - Long-term analysis of cell communication in mixed cultures - Potential applications in organoids and tumor microenvironments Until now, studying the ...

STADA Arzneimittel AG

Press Release: STADA strengthens CHC local hero brand portfolio by acquiring Locobase derma line in Nordics

STADA strengthens CHC local hero brand portfolio by acquiring Locobase derma line in Nordics - STADA strengthens Consumer Healthcare presence in Nordic countries by acquiring rights to Locobase® dermatology brand - Locobase® range of 17 products ...

LTS Lohmann Therapie-Systeme AG

LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions

Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company specializing in advanced drug delivery systems, today announced the expansion of its service portfolio to include CDMO services for ophthalmic drug delivery solutions, with manufacturing capacities located in the United States at LTS’ Lakewood, New Jersey facility. The new offering focuses initially on product ...

VITUS Privatklinik Prof. Dr. Stehling GmbH

First Clinical Analysis of Electrochemotherapy in Prostate Cancer Shows 93% Response

OFFENBACH, Germany (ots) - Vitus Privatklinik reports the first and largest clinical cohort of electrochemotherapy in prostate cancer. Vitus Privatklinik published the first clinical analysis of electrochemotherapy in prostate cancer, involving 144 patients treated between 2017 and 2024. The report is the largest dataset to date on this treatment. Radical prostatectomy ...

LAUDA DR. R. WOBSER GMBH & CO. KG

2

LAUDA Presents the Dr.-Rudolf-Wobser-Medal to Indian Partner Sandeep Sawant